- Abiraterone acetate: A novel drug for castration-resistant prostate carcinomaR, NandhaJournal of Postgraduate Medicine, 2012, 58(3): 203.
- Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancerMeijun, Du; Yijun, Tian; Winston, Tan; Liewei, Wang; Liguo, Wang; Deepak, Kilari; Chiang-Ching, Huang; Liang, Wang; Manish, KohliPROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23(4): 705-713.被引 2
- Treatment patterns of prostate cancer with bone metastasis in Beijing: A real坼world study using data from an administrative claims databaseYinchu, Cheng; Lin, Zhuo; Yuting, Pan; Shengfeng, Wang; Jihong, Zong; Wentao, Sun; Shuangqing, Gao; Jian, Lu; Siyan, ZhanPharmacoepidemiology and Drug Safety, 2019, 28(11): 1501-1509.被引 2
会议论文
Phase II therapeutic equivalence study of Abiraterone Acetate Tablets (I) vs. ZYTIGA? in patients with metastatic castration-resistant prostate cancer.
13阅读
